ADL
SKYE icon

Asset Dedication LLC’s Skye Bioscience SKYE Stock Holding History

Asset Dedication LLC’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-16
Closed -$129 – 1261
2024
Q2 		$129 Buy
+16
New +$190 ﹤0.01% 1176

Other funds holding SKYE

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Asset Dedication LLC's SKYE Position: Q3 2024 in Review

Asset Dedication LLC sold out of Skye Bioscience (SKYE) in Q3 2024, closing a stake of 16 shares — an estimated $129 sold.

Asset Dedication LLC first reported a position in SKYE in Q2 2024 and held it in 1 quarter. The position peaked at $129 in Q2 2024. 74 funds tracked by Wall St. Rank hold SKYE as of Q3 2024.

  • Asset Dedication LLC reported no remaining Skye Bioscience position as of Q3 2024 after selling out during the quarter.
  • Asset Dedication LLC sold 16 Skye Bioscience shares in Q3 2024, an estimated $129.
  • Asset Dedication LLC first reported a position in Skye Bioscience in Q2 2024 and held it in 1 quarter.
  • Asset Dedication LLC's Skye Bioscience position peaked at $129 in Q2 2024.
  • 74 funds tracked by Wall St. Rank held Skye Bioscience as of Q3 2024.

Based on Asset Dedication LLC's 13F filing for Q3 2024, filed 15 Oct 2024.